C V Damaraju

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 1

Top Topics

Coronavirus Disease

Aortic Stenosis

Placebo Controlled

Top Venues

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

John A Spertus, Mary C Birmingham, Michael Nassif, C V Damaraju, Antonio Abbate, Javed Butler, David E Lanfear, Ildiko Lingvay, Mikhail Naum Kosiborod, James L Januzzi
The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial. Nature medicine 28 (4) (2022)